Commercialanti-CD19 CART cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European center

Autor: Sesques, P, Ferrant, E, Safar, V, Wallet, F, Tordo, J, Dhomps, A, Karlin, L, Brisou, G, Vercasson, M, Hospital-Gustem, C, Schwiertz, V, Ranchon, F, Rioufol, C, Choquet, M, Sujobert, P, Ghergus, D, Bouafia, F, Golfier, C, Lequeu, H, Lazareth, A, Novelli, S, Devic, P, Glehen, AT, Viel, S, Venet, F, Mialou, V, Hequet, O, Chauchet, A, Arkam, Y, Nicolas-Virelizier, E, Peyrade, F, Cavalieri, D, Ader, F, Ghesquieres, H, Salles, G, Bachy, E

Publikováno v: AMERICAN JOURNAL OF HEMATOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

Two autologous anti-CD19 chimeric antigen receptors (CAR) T cells (axicabtagene ciloleucel [axi-cel] and tisagenlecleucel [tisa-cel]) are commercially approved in Europe for relapsed/refractory (R/R) diffuse large B cell lymphoma (DLBCL). We performe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::490e3c3ba55ee9ebf4acbcde999f37a5
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=13578

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Effect of Porosity Shape, Size and Distribution on Stress Intensity Factors in Spot Welded Joints: A Finite Element Study.

Autor: Benala, Imen¹ imen.benala@univ-temouchent.edu.dz, Zouambi, Leila^2,3, Bouafia, Farida^1,2, Serier, Boualem³, Hayat, Sardar Sikandar⁴

Publikováno v: Annales de Chimie Science des Matériaux. Jun2023, Vol. 47 Issue 3, p151-157. 7p.

Clinicopathological features and survival in EBV-positive diffuse large B-cell lymphoma not otherwise specified.

Autor: Bourbon E; Service d'Hématologie, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre Bénite Cedex, France.; Université de Lyon, Université Claude Bernard Lyon 1, Villeurbanne, France., Maucort-Boulch D; Université de Lyon, Université Claude Bernard Lyon 1, Villeurbanne, France.; Service de Biostatistique et Bioinformatique, Pôle Santé Publique, Hospices Civils de Lyon, Lyon, France.; Centre national de la recherche scientifique (CNRS), Unité Mixte de Recherche (UMR) 5558, Laboratoire de Biométrie et Biologie Évolutive, Équipe Biostatistique-Santé, Villeurbanne, France., Fontaine J; Service d'Anatomie Pathologique, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre Bénite Cedex, France., Mauduit C; Service d'Anatomie Pathologique, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre Bénite Cedex, France., Sesques P; Service d'Hématologie, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre Bénite Cedex, France., Safar V; Service d'Hématologie, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre Bénite Cedex, France., Ferrant E; Service d'Hématologie, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre Bénite Cedex, France., Golfier C; Service d'Hématologie, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre Bénite Cedex, France., Ghergus D; Service d'Hématologie, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre Bénite Cedex, France., Karlin L; Service d'Hématologie, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre Bénite Cedex, France., Lazareth A; Service d'Hématologie, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre Bénite Cedex, France., Bouafia F; Service d'Hématologie, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre Bénite Cedex, France., Pica GM; Service d'Hématologie, Centre hospitalier Métropole Savoie, Chambéry, France., Orsini-Piocelle F; Service d'Hématologie, Hôpital Annecy-Genevois, Annecy, France., Rocher C; Service d'Hématologie, Groupement Hospitalier Nord Dauphiné, Bourgoin Jallieu, France., Gros FX; Service d'Hématologie clinique et de Thérapies cellulaires and., Parrens M; Service d'Anatomie et de Pathologie, Centre Hospitalo-Universitaire de Bordeaux, Bordeaux, France.; INSERM U1053, BaRITOn, Université de Bordeaux, Bordeaux, France., Dony A; Service d'Hématologie, Hôpital Nord-Ouest, Villefranche-sur-Saône, France., Rossi C; Service d'Hématologie, Centre Hospitalier Universitaire de Dijon, Dijon, France.; INSERM UMR 1231, Dijon, France., Ghesquières H; Service d'Hématologie, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre Bénite Cedex, France.; Université de Lyon, Université Claude Bernard Lyon 1, Villeurbanne, France.; EA LIB (Lymphoma ImmunoBiology), Université Claude Bernard Lyon 1, Lyon, France; and., Bachy E; Service d'Hématologie, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre Bénite Cedex, France.; Université de Lyon, Université Claude Bernard Lyon 1, Villeurbanne, France.; EA LIB (Lymphoma ImmunoBiology), Université Claude Bernard Lyon 1, Lyon, France; and., Traverse-Glehen A; Université de Lyon, Université Claude Bernard Lyon 1, Villeurbanne, France.; Service d'Anatomie Pathologique, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre Bénite Cedex, France.; EA LIB (Lymphoma ImmunoBiology), Université Claude Bernard Lyon 1, Lyon, France; and., Sarkozy C; Département d'Innovation thérapeutique, Institut Gustave Roussy, Villejuif, France.

Publikováno v: Blood advances [Blood Adv] 2021 Aug 24; Vol. 5 (16), pp. 3227-3239.

Commercial anti-CD19 CAR T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European center.

Autor: Sesques P; Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France.; Claude Bernard Lyon 1 University, Lyon, France., Ferrant E; Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France., Safar V; Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France., Wallet F; Department of Critical Care, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France., Tordo J; Department of Nuclear Medicine, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France., Dhomps A; Department of Nuclear Medicine, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France., Karlin L; Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France., Brisou G; Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France.; Claude Bernard Lyon 1 University, Lyon, France., Vercasson M; Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France., Hospital-Gustem C; Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France., Schwiertz V; Department of Pharmacy, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France., Ranchon F; Claude Bernard Lyon 1 University, Lyon, France.; Department of Pharmacy, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France., Rioufol C; Claude Bernard Lyon 1 University, Lyon, France.; Department of Pharmacy, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France., Choquet M; Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France., Sujobert P; Claude Bernard Lyon 1 University, Lyon, France.; Department of Hematology Laboratory, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France.; Lyon Cancer Research Center, INSERM U1052 and CNRS UMR5286, Lyon, France., Ghergus D; Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France., Bouafia F; Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France., Golfier C; Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France.; Claude Bernard Lyon 1 University, Lyon, France., Lequeu H; Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France., Lazareth A; Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France., Novelli S; Lyon Cancer Research Center, INSERM U1052 and CNRS UMR5286, Lyon, France., Devic P; Department of Neurology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France., Traverse Glehen A; Claude Bernard Lyon 1 University, Lyon, France.; Lyon Cancer Research Center, INSERM U1052 and CNRS UMR5286, Lyon, France.; Department of Pathology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France., Viel S; Claude Bernard Lyon 1 University, Lyon, France.; Department of Biological Immunology, Hospices Civils de Lyon, Lyon Sud Hospital, Lyon, France.; International Center for Research in Infectious Diseases, INSERM U1111 and CNRS UMR5308, Lyon, France., Venet F; Claude Bernard Lyon 1 University, Lyon, France.; Department of Clinical Immunology, Hospices Civils de Lyon, Edouard Herriot Hospital, Lyon, France., Mialou V; Department of Biology and Therapy, Etablissement Français du Sang Auvergne-Rhône-Alpes, Decines-Charpieu, France., Hequet O; Department of Biology and Therapy, Etablissement Français du Sang Auvergne-Rhône-Alpes, Decines-Charpieu, France., Chauchet A; Department of Hematology, Besançon University Hospital, Besançon, France., Arkam Y; Department of Hematology, Hopital Emile Muller, Mulhouse, France., Nicolas-Virelizier E; Department of Hematology, Centre Léon Bérard, Lyon, France., Peyrade F; Department of Hematology, Centre Antoine Lacassagne, Nice, France., Cavalieri D; Department of Hematology, Clermont Ferrand University Hospital, Clermont Ferrand, France., Ader F; Department of Infectious Disease, Hospices Civils de Lyon, Croix Rousse Hospital, Lyon, France., Ghesquières H; Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France.; Claude Bernard Lyon 1 University, Lyon, France.; Lyon Cancer Research Center, INSERM U1052 and CNRS UMR5286, Lyon, France., Salles G; Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France.; Claude Bernard Lyon 1 University, Lyon, France.; Lyon Cancer Research Center, INSERM U1052 and CNRS UMR5286, Lyon, France., Bachy E; Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France.; Claude Bernard Lyon 1 University, Lyon, France.; Lyon Cancer Research Center, INSERM U1052 and CNRS UMR5286, Lyon, France.

Publikováno v: American journal of hematology [Am J Hematol] 2020 Nov; Vol. 95 (11), pp. 1324-1333. Date of Electronic Publication: 2020 Aug 25.